Home > Balance Sheet > NGL FINECHEM

NGL FINECHEM
Total Non-Current Liabilities

    Back to Balance Sheet
NGL FINECHEM is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Total Non-Current Liabilities ₹6.32 Cr₹6.24 Cr₹8.06 Cr₹11 Cr₹12 Cr

What is the latest Total Non-Current Liabilities ratio of NGL FINECHEM ?

The latest Total Non-Current Liabilities ratio of NGL FINECHEM is ₹6.32 Cr based on Mar2024 Consolidated results.
Year Total Non-Current Liabilities
Mar2024₹6.32 Cr
Mar2023₹6.24 Cr
Mar2022₹8.06 Cr
Mar2021₹11 Cr
Mar2020₹12 Cr

How is Total Non-Current Liabilities of NGL FINECHEM Trending?

Years Total Non-Current Liabilities % Change
Mar2024 ₹6.32 Cr
1.27
Mar2023 ₹6.24 Cr
-22.60
Mar2022 ₹8.06 Cr
-27.82
Mar2021 ₹11 Cr
-3.92
Mar2020 ₹12 Cr -

Compare Total Non-Current Liabilities of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹714.9 Cr -0.3% 10.2% -45.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹411,306.0 Cr -2.5% 7.6% 4.7% Stock Analytics
DIVIS LABORATORIES ₹150,343.0 Cr -3% 3.4% 61.5% Stock Analytics
CIPLA ₹117,323.0 Cr -1.6% 3% -3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹108,619.0 Cr -0.3% 9% 22.3% Stock Analytics
DR REDDYS LABORATORIES ₹95,941.5 Cr -1.2% 2.9% -6.4% Stock Analytics


NGL FINECHEM Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

-0.3%

10.2%

-45.6%

SENSEX

-1.8%

2.7%

5%


You may also like the below Video Courses